Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:00 pm Sale |
2023-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT |
Vivo Capital VIII LLC | 2,073,005 5.500% |
-200,000 (-8.80%) |
Filing History |
| 2023-02-13 5:57 pm Purchase |
2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Vivo Capital VIII LLC | 4,340,212 9.000% |
2,022,432 (+87.26%) |
Filing History |
| 2023-02-13 5:56 pm Sale |
2022-12-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY |
Vivo Capital VIII LLC | 2,571,024 4.300% |
-1,729,237 (-40.21%) |
Filing History |
| 2022-02-11 5:24 pm Unchanged |
2021-12-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY |
Vivo Capital VIII LLC | 4,300,261 7.400% |
0 (Unchanged) |
Filing History |
| 2022-02-11 5:22 pm Sale |
2021-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
Vivo Capital VIII LLC | 0 0.000% |
-1,819,600 (Position Closed) |
Filing History |
| 2022-02-11 5:21 pm Sale |
2021-12-31 | 13G | AMYRIS INC AMRSQ |
Vivo Capital VIII LLC | 7,734,621 2.500% |
-3,110,475 (-28.68%) |
Filing History |
| 2021-05-06 4:30 pm Purchase |
2021-04-27 | 13G | IPI LEGACY LIQUIDATION CO COMM IMPLQ |
Vivo Capital VIII LLC | 2,884,789 14.900% |
2,884,789 (New Position) |
Filing History |
| 2021-02-18 4:53 pm Purchase |
2021-02-09 | 13G | Terns Pharmaceuticals, Inc. TERN |
Vivo Capital VIII LLC | 2,317,780 9.700% |
2,317,780 (New Position) |
Filing History |
| 2021-02-18 4:50 pm Purchase |
2021-02-09 | 13G | Bolt Biotherapeutics, Inc. BOLT |
Vivo Capital VIII LLC | 2,273,005 6.600% |
2,273,005 (New Position) |
Filing History |
| 2021-02-12 4:30 pm Sale |
2020-12-31 | 13G | Passage Bio, Inc. PASG |
Vivo Capital VIII LLC | 1,487,038 11.000% |
-756,459 (-33.72%) |
Filing History |
| 2021-02-12 4:30 pm Sale |
2020-12-31 | 13G | AMYRIS INC AMRSQ |
Vivo Capital VIII LLC | 10,845,096 4.500% |
-37,560 (-0.35%) |
Filing History |
| 2021-02-12 4:30 pm Sale |
2020-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
Vivo Capital VIII LLC | 1,819,600 5.500% |
-425,304 (-18.95%) |
Filing History |
| 2021-02-12 4:30 pm Sale |
2020-12-31 | 13G | Kadmon Holdings, Inc. KDMN |
Vivo Capital VIII LLC | 4,283,014 2.500% |
-6,010,757 (-58.39%) |
Filing History |
| 2020-10-28 4:30 pm Purchase |
2020-10-20 | 13G | Aligos Therapeutics, Inc. ALGS |
Vivo Capital VIII LLC | 141,881 10.500% |
141,881 (New Position) |
Filing History |
| 2020-08-31 7:01 pm Purchase |
2020-08-21 | 13G | Harmony Biosciences Holdings, Inc. HRMY |
Vivo Capital VIII LLC | 4,300,261 6.700% |
4,300,261 (New Position) |
Filing History |
| 2020-06-11 5:09 pm Sale |
2020-06-09 | 13G | MENLO THERAPEUTICS INC MNLO |
Vivo Capital VIII LLC | 3,643,824 2.200% |
-367,412 (-9.16%) |
Filing History |
| 2020-06-11 5:06 pm Sale |
2019-06-10 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
Vivo Capital VIII LLC | 2,244,904 6.800% |
-853,416 (-27.54%) |
Filing History |